Navigation Links
Slim Line Oxygen Flowmeters - Adult

ProductsSlim Line Oxygen Flowmeters - Adult
Company Western Medica
Item Slim Line Oxygen Flowmeters - Adult
Features 
  • Adult
  • Brass and Aluminum
  • Oxygen, Medical Air and Carbon Dioxide Flowmeters available
  • Full line of inlet connections available
  • Calibrated at 50 psi inlet
  • Optional power take-off units provide 50 psi additional outlet pressure
  • Double units for multi-patient use from one wall outlet
  • Polycarbonate inner and outer tubes provide greater accuracy and durability
  • Description Slim Line Flowmeters with brass and aluminum body.

    Options:
  • For security chain, add suffix S to model number. Example: FME107S.
  • For Canadian Color-Code, add suffix C to model number. Example: FMA104C.
  • For Double Flowmeters with Power Take-Off, add PT to model number. Example: FMEPT409.
  • Info Western Medica
    Customer Service: (800) 783-7890
    Web site: http://www.westernmedica.com/

    Related medicine products :

    1. LICOX Brain Tissue Oxygen Monitoring System
    2. PULSOX-2 Oxygen Saturation Monitor
    3. LOTUS™ Electronic Oxygen Conserver (with alarm)
    4. OXYMATIC® 401 Electronic Oxygen Conserver
    5. LOTUS™ Electronic Oxygen Conserver (without alarm)
    6. OXYMATIC® 401A Electronic Oxygen Conserver
    7. OXYMATIC® 411A Electronic Oxygen Conserver
    8. OXYMATIC® 411 Electronic Oxygen Conserver
    9. OXYMATIC® 411AF Electronic Oxygen Conserver
    10. SEQUOIA OXYMATIC® 302 Electronic Oxygen Conserver
    11. SEQUOIA OXYMATIC® 312 Electronic Oxygen Conserver
    The Coreograft PLIF Allograft System is a wedge shaped, cortical strut designed to provide anterior column support and facilitate interbody fusion. This system includes a specially designed instrumen
    Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts
    VG2 PLIF Allograft is comprised of two cortical planks of bone surrounding a cancellous center. The cortical planks provide strength for anterior column support. The cancellous bone provides a lattic
    Ramp allograft is machined from cortical bone to combine column support. The graft is machined with a textured surface for increased stability and resistance to graft migration. This allograft can be
    Medicine Products:
    (Date:7/25/2008)...ients consumers tips and encourages them to, ,Spe...G, Pa., July 25 /PRNewswire-USNewswire/ -- The Pen..."National Patient Safety Day" which,is a national ...,participate fully in their healthcare by asking q...eir surgery or illness., "We understand the impor...
    (Date:7/25/2008)...f Marketing Exclusivity Begins -, CORONA, Calif.,...uticals, Inc. (NYSE: WPI ), a leading specialty p...bsidiary has commenced commercial,shipment of its ... the 40mg,strength from its Davie, Florida manufac...atson has 180 days of marketing exclusivity for be...
    (Date:7/25/2008)...rapy Alliance to be presented at Fenway Park ...I., July 25 /PRNewswire/ -- CVS/pharmacy announced...ing $4.4 million in just 21 days,through its annua...This is,the seventh year of the annual fundraising...illion for ALS research. This year,s fundraiser to...
    (Date:7/25/2008)...e Retina Group of New York will present an educati...ation especially designed for seniors. The lecture... 116 Merritts Road, Farmingdale, NY 11735, 1:00 to...e and refreshments will be provided. The phone num... Hicksville and Hauppauge, NY ...
    Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3
    ...thod of treating childhood brain tumours, aimed at...to be trialled at hospitals around the US. Researc...blastoma – the most common malignant childhood bra...ower radiation and increased chemotherapy doses th...
    ...only used in vitro fertilisation (IVF) technique i...e the risk of babies being born with abnormalities... Pasteur Institute in Paris, France, say that men ...ther, more serious genetic faults that can be pass...
    ...g to a new study infants born during the night hav...h than those born during the day. There is also a ... which may be partly explained by hospital staff s...ours between 5pm and 1am are high risk periods for...
    ...ng drugs via nasal spray might overcome a major ob...according to researchers.Based on early studies in...er's Research Center in St. Paul, Minnesota, repor...nā€ could breach the blood-brain barrier, which pro...
    Other Medicine News:Health News:Nasal Spray Could Take Drugs Directly to Brain 2
    (Date:7/24/2008)...RLEANS, July 24 /PRNewswire-USNewswire/ -- There a...mental illnesses, according to a new,report releas...e,devastating effects that mental illnesses have o...e, mental illness affects nearly 60 million Americ... Research and Manufacturers,of America (PhRMA), fe...
    (Date:7/24/2008)...ORK, July 24 /- MacroChem C...ced results of a Phase 2 clinical trial,involving ...nter,open-label efficacy and safety study of EcoN...t of onychomycosis (nail fungus). The composite,pr... cure" defined as,negative mycology (negative fung...
    (Date:7/23/2008)...LE, July 23 /- Sound Pharmaceuticals ...ation with the FDA for the clinical,testing of a p...on of,chemotherapy induced hearing loss or ototoxi...5, will be tested in advanced stage lung cancer,an... based chemotherapy.,This marks the second develop...
    (Date:7/23/2008)...RANCISCO, July 23 /- InCode BioPharma...ny, today announced preclinical test,results demon...rC3-1 for,the treatment of the rare chronic blood .... The complete results will be presented at the XX...tzerland, September 28,2008., The only treatment...
    Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Schering Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter Full Year Financial Result 2393 1Schering Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter Full Year Financial Result 2393 2FOXO factor promotes survival of oxygen deprived cancer cells 8854 1FOXO factor promotes survival of oxygen deprived cancer cells 8854 2New research tools are too complex for easy answers researchers say 8852 1New research tools are too complex for easy answers researchers say 8852 2New research tools are too complex for easy answers researchers say 8852 3Copy number variation may stem from replication misstep 1735 1Copy number variation may stem from replication misstep 1735 2Copy number variation may stem from replication misstep 1735 3
    ...esented at Society of Nuclear,Medicine Annual Meet...Call/ --,Immunomedics, Inc. , a biopharmaceutical ...s to treat cancer and other serious,diseases, toda...,(CEA) antibody, labetuzumab, labeled with the rad...tive when given in two doses,to patients with colo...
    ... /PRNewswire/ -- , - Cipralex Better Tolerated and... Lundbeck A/S announces new study data published t...pinion, demonstrating that,Cipralex(R) (escitalopr...ent of patients with major depressive disorder (MD...eatment(1). The study,directly compared Cipralex(R...
    Other Medicine Technology:Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 2Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 3Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 4Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 5